RealView Imaging
Last updated: May 9, 2026
RealView Imaging is an Israeli medical holography startup that develops HOLOSCOPE-i, the world's first holographic display system that creates interactive 3D holograms in mid-air from live medical imaging data, enabling physicians to visualize and interact with patient anatomy in real-time.
Visit WebsiteCompany Overview
RealView Imaging, founded in 2008, is an Israeli medical technology pioneer developing the world's first practical volumetric holographic display system for clinical and commercial use. The company's flagship HOLOSCOPE-i system generates interactive 3D holograms floating in free space from real-time medical imaging data (ultrasound, CT, MRI, angiography), enabling physicians to visualize patient anatomy without glasses, headsets, or other wearables. The technology uses proprietary Digital Light Shaping™ technology to modulate light patterns, creating true volumetric representations with full 360-degree viewability and tactile spatial interaction.
The clinical value is substantial: interventional cardiologists performing structural heart procedures (atrial septal defect closure, mitral valve repair, transcatheter aortic valve implantation) gain unprecedented 3D spatial understanding of complex patient anatomy, potentially reducing procedure time, improving precision, and reducing complications. Beyond cardiology, the platform addresses vascular, orthopedic, and neurosurgical interventions. Unlike AR/VR headsets that constrain the surgeon's field of view and require device calibration, RealView's mid-air holograms maintain surgeons' natural vision while adding high-fidelity 3D context. This advantage is especially critical in sterile operating room environments where device donning, calibration, and hygiene are practical obstacles.
The technology's strategic and dual-use significance is substantial. Military medical applications include real-time holographic surgical guidance for combat medics in austere or field environments, enabling trauma surgeons to visualize complex injuries before arrival at surgical facilities. Command and control visualization—where holographic terrain, unit positions, and mission parameters can be collaboratively displayed in 3D space—directly parallels interventional cardiology use cases and extends to operational planning, intelligence analysis, and strategic briefing. Combat air crew training, maritime navigation in contested environments, and military logistical visualization represent credible extensions. Holographic 3D display technology is recognized as a dual-use frontier technology, and RealView's maturity in volumetric rendering positions the company as a strategic technology source.
Commercially, RealView has achieved clinical deployments in interventional cardiology centers across Europe, the United States, and Asia, with regulatory clearances including CE marking and FDA 510(k) clearance for certain imaging applications. The company has secured multi-million-dollar funding from both strategic medical technology investors and venture capital, and maintains strong technical leadership, including a co-founder (Shaul Gelman) with 17 years of AR/HMD experience at Elbit Systems, Israel's largest defense company. The addressable market spans interventional cardiology (approximately 2 million procedures annually in developed markets), vascular intervention, orthopedic and spine surgery, and neurosurgery—representing a multi-billion-dollar opportunity for premium 3D visualization tools that improve clinical outcomes.
Dual-Use Assessment
Holographic 3D visualization technology has direct dual-use pathways: (1) Combat medicine—holographic rendering of casualty imaging (ultrasound, portable CT) enables field trauma surgeons to pre-plan surgical approaches before evacuation or in-theater arrival, critical for complex thoracic, abdominal, or vascular injuries; (2) Command and control—interactive 3D terrain, unit positions, and intelligence overlays in a shared holographic space support collaborative strategic and operational planning without requiring individual headsets or displays; (3) Intelligence analysis—holographic 3D representation of SAR, signals, or geospatial data enables visual pattern recognition and team briefing; (4) Training and simulation—procedural training in complex medical or operational scenarios translates from cardiology to military medicine; (5) Unmanned systems coordination—holographic display of sensor data from aerial, maritime, or ground assets. Unlike pure commercial AR/VR, holographic volumetric rendering is a frontier military technology, and RealView's mature clinical integration represents a proven pathway for defense adaptation.
Strategic Fit Assessment
Priority signal means this entry may be worth researching within the Claw & Talon thesis. It does not mean investable, suitable, endorsed, available, or likely to produce returns.
RealView Imaging combines world-first volumetric holographic technology with proven clinical adoption, strong regulatory pathway, and direct dual-use applicability to military medical triage and command visualization. The company operates in a structurally undersaturated market (holographic 3D is early but validated) with technology barriers protecting against commodity competition. Founders bring deep expertise in both medical devices (regulatory, clinical evidence) and advanced AR/defense systems (Elbit Systems), rare in startup founders. Clinical evidence, though early, demonstrates time and complication reductions in complex procedures, supporting premium pricing in a high-stakes market. Strategic value to defense and aerospace entities as a native volumetric 3D platform makes the company strategically relevant for dual-use capital.
Strategic Value to U.S.-Israel Alliance
Unique volumetric holographic rendering platform with proven clinical-grade 3D visualization pipeline and real-time medical imaging integration, directly transferable to military command center visualization, combat medical guidance systems, and strategic intelligence briefing. The technology is not easily replicated by pure AR/VR competitors because it solves a materially different problem: true hands-free 360-degree 3D without devices. Strategic value to defense agencies includes: (1) field surgical planning and guidance in contested environments, (2) collaborative holographic mission planning and asset visualization, (3) intelligence and signals analysis via 3D holographic representation, (4) training and simulation for complex procedural tasks. Israeli origin provides alignment with established deep-tech defense partnerships and proven government technology insertion pathways.
Key Technologies
- Digital light shaping for volumetric holographic projection
- Real-time 3D hologram generation from medical imaging data
- Interactive mid-air holographic display without glasses/headsets
- Medical imaging data to hologram rendering pipeline
- Spatial interaction with floating 3D holographic objects
Use Cases & Applications
- Interventional cardiology holographic guidance during complex structural heart procedures
- Combat medical triage and surgical planning from field imaging
- Collaborative 3D terrain and mission planning for military operations
- Command center holographic operational display and asset visualization
- Intelligence analysis and 3D holographic briefings from geospatial and signals data
- Vascular intervention and endovascular procedure guidance
- Military medical training and surgical simulation without wearables
- Orthopedic and spine surgery pre-operative planning
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- Official website Primary public reference for company identity, positioning, and current web presence.
- Profile update timestamp Last updated in the Claw & Talon database on May 9, 2026.
Investor Lens
What this entry is
Private startup
Why it may matter
RealView Imaging may matter as a Health & BioTech entry with direct private-company diligence for Israeli technology research.
How an independent investor should read this
Direct private-company diligence. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify traction
- Verify cap table/funding
- Verify technical claims
- Verify regulatory/export-control issues
- Verify customer concentration
Main investor questions
- Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
- What customer, revenue, product, and technical evidence supports the company story?
- What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
- Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies RealView Imaging's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
- What regulatory, procurement, and buyer-adoption constraints could slow deployment in strategic or government-adjacent markets?
- What would disconfirm the priority signal: weak customer references, thin technical differentiation, poor capital efficiency, or limited allied-market access?
Related sector
See the Health & BioTech sector page for market context, related subcategories, and other Israeli companies in this part of the database.
Related companies
Need a diligence readout?
Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.